IL-6 Drug Promising in Depression; U.S. More Anxious; AI Risks in Addiction Medicine
(MedPage Today) -- A single infusion of the interleukin (IL)-6 inhibitor tocilizumab (Actemra) showed greater improvements in depression severity, somatic ...
Tag: inAddiction